Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New quinolone from Bayer undergoing extensive evaluation

Sep. 20, 1996

Potential new analgesic agent from SmithKline Beecham

Sep. 20, 1996

Stroke Update

Sep. 13, 1996

Orally active GH secretagogues with a short duration of action

Sep. 13, 1996

Achiral inhibitors of carnitine palmitoyltransferase I

Sep. 13, 1996

Warner-Lambert focuses on endothelin antagonists

Sep. 13, 1996

Merck & Co. describes endothelin antagonists

Sep. 13, 1996

Selective dual inhibitor of PDE I and PDE V from Schering-Plough

Sep. 13, 1996

Potential antiasthmatic agent from Lipha

Sep. 13, 1996

New cholinergic channel activators described by Abbott

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...